Transcriptional Control of Somatic Cell Reprogramming

Trends in Cell Biology

Volumn 26, Issue 4, 2016, Pages 272-288

  Xu, Yan ^a   Zhang, Meng ^a,b   Li, Wenjuan ^a,b   Zhu, Xihua ^a   Bao, Xichen ^a   Qin, Baoming ^a   Hutchins, Andrew P ^a   Esteban, Miguel A ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Epigenetic remodeling; Genome architecture; Pioneer transcription factors; Somatic cell reprogramming; Transcriptional regulation

Indexed keywords

MYC PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; MYC PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

BINDING SITE; CELL FATE; CHROMATIN; DNA METHYLATION; ENHANCER REGION; GENE EXPRESSION; GENOME; HUMAN; INDUCED PLURIPOTENT STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; REVIEW; RNA SEQUENCE; SOMATIC CELL; THREE DIMENSIONAL PRINTING; TRANSCRIPTION ELONGATION; TRANSCRIPTION REGULATION; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84954304849     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2015.12.003     Document Type: Review

References (168)

1. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
2. Liang G., Zhang Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 2013, 13:149-159.
3. Apostolou E., Hochedlinger K. Chromatin dynamics during cellular reprogramming. Nature 2013, 502:462-471.
4. Banito A., Gil J. Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep. 2010, 11:353-359.
5. Li R., et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7:51-63.
6. Samavarchi-Tehrani P., et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
7. Pfeiffer T., et al. Cooperation and competition in the evolution of ATP-producing pathways. Science 2001, 292:504-507.
8. Zhang J., et al. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 2012, 11:589-595.
9. Brambrink T., et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2:151-159.
10. Stadtfeld M., et al. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008, 2:230-240.
11. Cacchiarelli D., et al. Integrative analyses of human reprogramming reveal dynamic nature of induced pluripotency. Cell 2015, 162:412-424.
12. Polo J.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
13. Silva J., et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008, 6:e253.
14. Golipour A., et al. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. Cell Stem Cell 2012, 11:769-782.
15. Mikkelsen T.S., et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
16. Gurdon J.B., Wilmut I. Nuclear transfer to eggs and oocytes. Cold Spring Harb. Perspect. Biol. 2011, 3:a002659.
17. Gorkin D.U., et al. The 3D genome in transcriptional regulation and pluripotency. Cell Stem Cell 2014, 14:762-775.
18. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
19. SoufiA., et al. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 2012, 151:994-1004.
20. SoufiA., et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 2015, 161:555-568.
21. Aksoy I., et al. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm. EMBO J. 2013, 32:938-953.
22. Li W., et al. Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell 2013, 13:270-283.
23. Esteban M.A., et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6:71-79.
24. Wang T., et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 2011, 9:575-587.
25. Esteban M.A., Pei D. Vitamin C improves the quality of somatic cell reprogramming. Nat. Genet. 2012, 44:366-367.
26. Wernig M., et al. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008, 2:10-12.
27. Nakagawa M., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008, 26:101-106.
28. Cheng S.W., et al. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet. 1999, 22:102-105.
29. Wang Y., et al. Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep. 2011, 12:373-378.
30. Hirai H., et al. Radical acceleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD. Stem Cells 2011, 29:1349-1361.
31. Wu Y., et al. Srebp-1 interacts with c-Myc to enhance somatic cell reprogramming. Stem Cells 2015, Published online September 21, 2015. 10.1002/stem.2209.
32. Kim D., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
33. Zhou H., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
34. Cho H.J., et al. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 2010, 116:386-395.
35. Lee J., et al. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 2012, 151:547-558.
36. Buganim Y., et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012, 150:1209-1222.
37. O'Malley J., et al. High-resolution analysis with novel cell-surface markers identifies routes to iPS cells. Nature 2013, 499:88-91.
38. Zhuang Q., et al. Class IIa histone deacetylases and myocyte enhancer factor 2 proteins regulate the mesenchymal-to-epithelial transition of somatic cell reprogramming. J. Biol. Chem. 2013, 288:12022-12031.
39. Zhu S., et al. Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signaling-directed lineage conversion. Nat. Protoc. 2015, 10:959-973.
40. Bar-Nur O., et al. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nat. Biotechnol. 2015, 33:761-768.
41. Maza I., et al. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Nat. Biotechnol. 2015, 33:769-774.
42. Shu J., et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 2013, 153:963-975.
43. Montserrat N., et al. Reprogramming of human fibroblasts to pluripotency with lineage specifiers. Cell Stem Cell 2013, 13:341-350.
44. Loh K.M., Lim B. A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell 2011, 8:363-369.
45. Sridharan R., et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009, 136:364-377.
46. Rao R.A., et al. Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci. Rep. 2015, 5:8229.
47. Thomas L.R., et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Mol. Cell 2015, 58:440-452.
48. Ang Y.S., et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 2011, 145:183-197.
49. Rais Y., et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013, 502:65-70.
50. Buganim Y., et al. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 2013, 14:427-439.
51. Luo M., et al. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells. Stem Cells 2013, 31:1278-1286.
52. Lujan E., et al. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature 2015, 521:352-356.
53. dos Santos R.L., et al. MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner. Cell Stem Cell 2014, 15:102-110.
54. Koche R.P., et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011, 8:96-105.
55. CheloufiS., et al. The histone chaperone CAF-1 safeguards somatic cell identity. Nature 2015, 528:218-224.
56. Taberlay P.C., et al. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell 2011, 147:1283-1294.
57. Doege C.A., et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 2012, 488:652-655.
58. Zhang H., et al. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell 2013, 13:30-35.
59. Wei Z., et al. Klf4 organizes long-range chromosomal interactions with the oct4 locus in reprogramming and pluripotency. Cell Stem Cell 2013, 13:36-47.
60. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012, 13:484-492.
61. Baumann K. Epigenetics: enhancers under TET control. Nat. Rev. Mol. Cell Biol. 2014, 15:699.
62. Gao Y., et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 2013, 12:453-469.
63. Di Stefano B., et al. C/EBPalpha poises B cells for rapid reprogramming into induced pluripotent stem cells. Nature 2014, 506:235-239.
64. Luperchio T.R., et al. Genome regulation at the peripheral zone: lamina associated domains in development and disease. Curr. Opin. Genet. Dev. 2014, 25:50-61.
65. Peric-Hupkes D., et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol. Cell 2010, 38:603-613.
66. Apostolou E., et al. Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming. Cell Stem Cell 2013, 12:699-712.
67. Denholtz M., et al. Long-range chromatin contacts in embryonic stem cells reveal a role for pluripotency factors and polycomb proteins in genome organization. Cell Stem Cell 2013, 13:602-616.
68. Schoenfelder S., et al. Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat. Genet. 2010, 42:53-61.
69. Kagey M.H., et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010, 467:430-435.
70. Zuo B., et al. Influences of lamin A levels on induction of pluripotent stem cells. Biol. Open 2012, 1:1118-1127.
71. Li M., et al. Navigating the epigenetic landscape of pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 2012, 13:524-535.
72. Polo J.M., et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 2010, 28:848-855.
73. Min I.M., et al. Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells. Genes Dev. 2011, 25:742-754.
74. Liu L., et al. Transcriptional pause release is a rate-limiting step for somatic cell reprogramming. Cell Stem Cell 2014, 15:574-588.
75. Goodrich J.A., Tjian R. Unexpected roles for core promoter recognition factors in cell-type-specific transcription and gene regulation. Nat. Rev. Genet. 2010, 11:549-558.
76. Pijnappel W.W., et al. A central role for TFIID in the pluripotent transcription circuitry. Nature 2013, 495:516-519.
77. Liu Z., et al. Control of embryonic stem cell lineage commitment by core promoter factor, TAF3. Cell 2011, 146:720-731.
78. Fuda N.J., et al. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 2009, 461:186-192.
79. Yik J.H., et al. Inhibition of P-TEFb (CDK9/cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell 2003, 12:971-982.
80. Wu S.Y., Chiang C.M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 2007, 282:13141-13145.
81. Wu T., et al. The BET family member BRD4 interacts with OCT4 and regulates pluripotency gene expression. Stem Cell Rep. 2015, 4:390-403.
82. Rahl P.B., et al. c-Myc regulates transcriptional pause release. Cell 2010, 141:432-445.
83. Chen X., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
84. Kim J., et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010, 143:313-324.
85. Kim J., et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008, 132:1049-1061.
86. Walz S., et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 2014, 511:483-487.
87. Sabo A., et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 2014, 511:488-492.
88. Xu Y., et al. Proliferation rate of somatic cells affects reprogramming efficiency. J. Biol. Chem. 2013, 288:9767-9778.
89. Whyte Warren A., et al. Master transcription factors and Mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
90. Li X., et al. Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons. Cell Stem Cell 2015, 17:195-203.
91. Nishimura K., et al. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming. Stem Cell Rep. 2014, 3:915-929.
92. Sridharan R., et al. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1gamma in reprogramming to pluripotency. Nat. Cell Biol. 2013, 15:872-882.
93. Onder T.T., et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012, 483:598-602.
94. Liang G., et al. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat. Cell Biol. 2012, 14:457-466.
95. Liu J., et al. The oncogene c-Jun impedes somatic cell reprogramming. Nat. Cell Biol. 2015, 17:856-867.
96. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
97. Fatica A., Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 2014, 15:7-21.
98. Chen T., et al. m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. Cell Stem Cell 2015, 16:289-301.
99. Aguilo F., et al. Coordination of mA mRNA methylation and gene transcription by ZFP217 regulates pluripotency and reprogramming. Cell Stem Cell 2015, 17:689-704.
100. Loewer S., et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 2010, 42:1113-1117.
101. Bao X., et al. The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res. 2015, 25:80-92.
102. Gabut M., et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011, 147:132-146.
103. Ohta S., et al. Global splicing pattern reversion during somatic cell reprogramming. Cell Rep. 2013, 5:357-366.
104. Lu Y., et al. Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. Cell Stem Cell 2014, 15:92-101.
105. Han H., et al. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 2013, 498:241-245.
106. Hirsch C.L., et al. Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming. Genes Dev. 2015, 29:803-816.
107. Kim D.H., et al. Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming. Cell Stem Cell 2015, 16:88-101.
108. Smallwood S.A., et al. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat. Methods 2014, 11:817-820.
109. Cusanovich D.A., et al. Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing. Science 2015, 348:910-914.
110. Nagano T., et al. Single-cell Hi-C reveals cell-to-cell variability in chromosome structure. Nature 2013, 502:59-64.
111. Guo S., et al. Nonstochastic reprogramming from a privileged somatic cell state. Cell 2014, 156:649-662.
112. Chen J., et al. Towards an optimized culture medium for the generation of mouse induced pluripotent stem cells. J. Biol. Chem. 2010, 285:31066-31072.
113. Woltjen K., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
114. Banito A., et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009, 23:2134-2139.
115. Li F., et al. Apoptotic caspases regulate induction of iPSCs from human fibroblasts. Cell Stem Cell 2010, 7:508-520.
116. Ruiz S., et al. A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr. Biol. 2011, 21:45-52.
117. Zhao W., et al. Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination. Cell 2013, 152:1037-1050.
118. Burdon T., et al. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 2002, 12:432-438.
119. Edel M.J., et al. Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1. Genes Dev. 2010, 24:561-573.
120. Ocana O.H., Nieto M.A. Epithelial plasticity, stemness and pluripotency. Cell Res. 2010, 20:1086-1088.
121. Ji J., et al. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells. Stem Cell Rep. 2014, 2:44-51.
122. Prigione A., et al. HIF1alpha modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2. Stem Cells 2014, 32:364-376.
123. Mathieu J., et al. Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency. Cell Stem Cell 2014, 14:592-605.
124. Singhal N., et al. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 2010, 141:943-955.
125. Jiang Z., et al. Knockdown of Brm and Baf170, components of chromatin remodeling complex, facilitates reprogramming of somatic cells. Stem Cells Dev. 2015, 24:2328-2336.
126. Jiang B.H., et al. CHD1L regulated PARP1-driven pluripotency and chromatin remodeling during the early-stage cell reprogramming. Stem Cells 2015, 33:2961-2972.
127. Lee M.R., et al. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells 2013, 31:666-681.
128. Wang L., et al. INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development. Cell Stem Cell 2014, 14:575-591.
129. Moon J.H., et al. Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res. 2011, 21:1305-1315.
130. Li W., et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009, 27:2992-3000.
131. Chen J., et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 2013, 45:34-42.
132. Shi Y., et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 2:525-528.
133. Tran K.A., et al. Collaborative rewiring of the pluripotency network by chromatin and signalling modulating pathways. Nat. Commun. 2015, 6:6188.
134. Qin H., et al. Systematic identification of barriers to human iPSC generation. Cell 2014, 158:449-461.
135. Mansour A.A., et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature 2012, 488:409-413.
136. Kidder B.L., et al. Extended self-renewal and accelerated reprogramming in the absence of Kdm5b. Mol. Cell. Biol. 2013, 33:4793-4810.
137. Vidal S.E., et al. Combinatorial modulation of signaling pathways reveals cell-type-specific requirements for highly efficient and synchronous iPSC reprogramming. Stem Cell Rep. 2014, 3:574-584.
138. Chu Z., et al. PRMT5 enhances generation of induced pluripotent stem cells from dairy goat embryonic fibroblasts via down-regulation of p53. Cell Prolif. 2015, 48:29-38.
139. Wei T., et al. An HDAC2-TET1 switch at distinct chromatin regions significantly promotes the maturation of pre-iPS to iPS cells. Nucleic Acids Res. 2015, 43:5409-5422.
140. Mu W.L., et al. Sox2 deacetylation by Sirt1 is involved in mouse somatic reprogramming. Stem Cells 2015, 33:2135-2147.
141. Lee Y.L., et al. Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse embryonic fibroblasts through the miR-34a and p53 pathways. PloS ONE 2012, 7:e45633.
142. Sharma A., et al. The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J. Biol. Chem. 2013, 288:18439-18447.
143. Bhutani N., et al. A critical role for AID in the initiation of reprogramming to induced pluripotent stem cells. FASEB J. 2013, 27:1107-1113.
144. Bhutani N., et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
145. Kumar R., et al. AID stabilizes stem-cell phenotype by removing epigenetic memory of pluripotency genes. Nature 2013, 500:89-92.
146. Hu X., et al. Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming. Cell Stem Cell 2014, 14:512-522.
147. Chen J., et al. The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells. Stem Cells 2015, 33:686-698.
148. Costa Y., et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 2013, 495:370-374.
149. Chen J., et al. Vitamin C modulates TET1 function during somatic cell reprogramming. Nat. Genet. 2013, 45:1504-1509.
150. Gonzalez-Munoz E., et al. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming. Science 2014, 345:822-825.
151. Pasque V., et al. Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J. Cell Sci. 2012, 125:6094-6104.
152. Gaspar-Maia A., et al. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat. Commun. 2013, 4:1565.
153. Barrero M.J., et al. Macrohistone variants preserve cell identity by preventing the gain of H3K4me2 during reprogramming to pluripotency. Cell Rep. 2013, 3:1005-1011.
154. Shinagawa T., et al. Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells. Cell Stem Cell 2014, 14:217-227.
155. Yang P., et al. RCOR2 is a subunit of the LSD1 complex that regulates ESC property and substitutes for SOX2 in reprogramming somatic cells to pluripotency. Stem Cells 2011, 29:791-801.
156. Feng B., et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 2009, 11:197-203.
157. Heng J.C., et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010, 6:167-174.
158. Maekawa M., et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 2011, 474:225-229.
159. Picanco-Castro V., et al. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A. Stem Cells Dev. 2011, 20:169-180.
160. Redmer T., et al. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep 2011, 12:720-726.
161. Kawamura T., et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1144.
162. Bao X., et al. MicroRNAs in somatic cell reprogramming. Curr. Opin. Cell Biol. 2013, 25:208-214.
163. Anokye-Danso F., et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8:376-388.
164. Miyoshi N., et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011, 8:633-638.
165. Hou P., et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341:651-654.
166. Long Y., et al. Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells. Cell Res. 2015, 25:1171-1174.
167. Han D.W., et al. Direct reprogramming of fibroblasts into epiblast stem cells. Nat. Cell Biol. 2011, 13:66-71.
168. Tonge P.D., et al. Divergent reprogramming routes lead to alternative stem-cell states. Nature 2014, 516:192-197.